Cell Impact AB (CI) — Cash Flow-to-Debt Ratio
Cell Impact AB (CI) has a Cash Flow-to-Debt Ratio of -0.67x as of September 2025, meaning its operating cash flow of Skr-19.56 Million could theoretically repay -1% of its total liabilities (Skr29.21 Million) in one year. Check CI cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cell Impact AB Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for Cell Impact AB across 13 annual periods. Also explore total assets of Cell Impact AB for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Cell Impact AB (2012–2024)
Year-by-year debt coverage analysis for Cell Impact AB. For market capitalisation and broader financial context, see Cell Impact AB market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.48x | Skr-62.23 Million | Skr42.16 Million | ▼ -14.8% |
| 2023 | -1.29x | Skr-100.97 Million | Skr78.56 Million | ▲ +6.4% |
| 2022 | -1.37x | Skr-105.93 Million | Skr77.17 Million | ▼ -53.3% |
| 2021 | -0.90x | Skr-86.08 Million | Skr96.10 Million | ▲ +22.9% |
| 2020 | -1.16x | Skr-47.59 Million | Skr40.99 Million | ▲ +63.2% |
| 2019 | -3.16x | Skr-41.01 Million | Skr12.98 Million | ▼ -40.5% |
| 2018 | -2.25x | Skr-42.57 Million | Skr18.94 Million | ▲ +8.2% |
| 2017 | -2.45x | Skr-15.84 Million | Skr6.47 Million | ▼ -204.4% |
| 2016 | -0.80x | Skr-8.92 Million | Skr11.10 Million | ▲ +22.9% |
| 2015 | -1.04x | Skr-5.56 Million | Skr5.33 Million | ▲ +45.1% |
| 2014 | -1.90x | Skr-5.86 Million | Skr3.08 Million | ▲ +21.2% |
| 2013 | -2.41x | Skr-7.86 Million | Skr3.26 Million | ▼ -13.0% |
| 2012 | -2.13x | Skr-7.80 Million | Skr3.66 Million | — |